Alle disse tillægsfaktorer ved anæmi bør også tages i betragtning, når det besluttes at øge dosis af epoetin alfa til cancerpatienter.
All of these additive factors of anaemia should also be carefully considered when deciding to increase the dose of epoetin alfa in cancer patients.